# Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer

> **NCT00004873** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute**

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00004873
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004873, "Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00004873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*